{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:14:35Z","timestamp":1759990475626},"reference-count":10,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,10,25]],"date-time":"2005-10-25T00:00:00Z","timestamp":1130198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Systemic coccidioidomycosis was diagnosed in a 4\u2010year\u2010old male chimpanzee (<jats:italic>Pan troglodytes<\/jats:italic>) with ascites and failure to thrive. Physical examination, laboratory and radiological studies, and exploratory laparotomy showed signs of systemic fungal infection that included penetration into the central nervous system (CNS). Serum and cerebrospinal fluid (CSF) titres, along with ascites cytology findings, confirmed the presence of <jats:italic>Coccidioides immitis<\/jats:italic>. However, the organism could not be cultured from the CSF. Treatment with fluconazole 10\u2003mg\u2003kg<jats:sup>\u22121<\/jats:sup> daily for 6\u2003months was not associated with clinical improvement. Subsequent treatment with posaconazole 50\u2003mg\u2003kg<jats:sup>\u22121<\/jats:sup> daily for approximately 24\u2003months resulted in negative serum titres and improved clinical status. Illness not directly related to the <jats:italic>C. immitis<\/jats:italic> infection caused the chimpanzee's deterioration and eventual killing. Histological examination performed during necropsy provided no evidence of coccidioidomycosis; however, a positive <jats:italic>C. immitis<\/jats:italic> serum antibody titre was noted. The successful suppression of coccidioidomycosis observed in this chimpanzee suggests that posaconazole may have a role in the treatment of CNS infections caused by susceptible fungi.<\/jats:p>","DOI":"10.1111\/j.1439-0507.2005.01155.x","type":"journal-article","created":{"date-parts":[[2005,10,25]],"date-time":"2005-10-25T12:06:00Z","timestamp":1130241960000},"page":"447-452","source":"Crossref","is-referenced-by-count":15,"title":["Posaconazole therapy for systemic coccidioidomycosis in a chimpanzee (<i>Pan troglodytes<\/i>): a case report"],"prefix":"10.1111","volume":"48","author":[{"given":"Kimberly Vinette","family":"Herrin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Loebenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,10,25]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/315401"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/319203"},{"key":"e_1_2_5_4_2","volume-title":"Zoo & Wild Animal Medicine: Current Therapy 3","author":"Fowler ME","year":"1993"},{"key":"e_1_2_5_5_2","unstructured":"MenseM.Southwest Foundation for Biomedical Research Air Force Research Laboratory Case Report 1 (98 AFIP Vet Path WSC 23). Available at:http:\/\/www.afip.org\/vetpath\/WSC\/wsc98\/98wsc23.htm."},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.3.2.91"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.5.1352-1356.2002"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.7.1558"},{"key":"e_1_2_5_9_2","unstructured":"CatanzaroA CloudG StevensDet\u00a0al.Safety and tolerance of posaconazole (SCH 56592) in patients with nonmeningeal disseminated coccidioidomycosis. Presented at: 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17\u201320 Toronto ON Canada.2000."},{"key":"e_1_2_5_10_2","unstructured":"AnsteadG CorcoranG LewisJ BergD GraybillJ.Posaconazole therapy for coccidioidomycosis: a case series. Abstract presented at: 41st Annual Meeting of the Infectious Diseases Society of America; October 9\u201312. San Diego CA USA 2003."},{"key":"e_1_2_5_11_2","first-page":"450","article-title":"Efficacy of posaconazole (POS) in treatment of central nervous system (CNS) fungal infections: results of an open\u2010label study [abstract]","volume":"47","author":"Pitisuttithum P","year":"2003","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.2005.01155.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1439-0507.2005.01155.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T21:20:53Z","timestamp":1696886453000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.2005.01155.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,25]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1111\/j.1439-0507.2005.01155.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.2005.01155.x","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,25]]}}}